The National Medical Products Administration (NMPA) has released the 89th batch of reference drugs for generic quality consistency evaluation (GQCE) work. This batch aims to enhance the quality and consistency of generic drugs in the market.
Batch Details
The 89th batch includes 51 new specifications and 28 specifications with modifications. The modifications primarily relate to changing generic names or adding Marketing Authorization Holders (MAHs) or English names. These updates are designed to align with international standards and improve the regulatory framework for generic drugs.
Significance of the GQCE
The Generic Quality Consistency Evaluation (GQCE) is a critical initiative by the NMPA to ensure that generic drugs meet the same high standards as their branded counterparts. By regularly updating the reference drug list, the NMPA aims to enhance the quality and safety of generic medications, benefiting both healthcare providers and patients.-Fineline Info & Tech
